COSMETIC / DIRECT CATALOG PRICING
SNAP-8
SNAP-8 is acetyl octapeptide-3 (Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-amide), according to the PubChem identity record.
- Format
- Lyophilized research vial
- Listed formats
- 1
- Available now
- 0
- Catalog class
- Cosmetic
- 200 mgPricing by inquiry · AvailableSelect
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
SNAP-8 is acetyl octapeptide-3 (Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-amide), according to the PubChem identity record.
The cosmetic classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Cosmetic
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- Contact for current availability
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
SNAP-8 is acetyl octapeptide-3 (Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-amide), according to the PubChem identity record.
- Research covered
- A 24-person comparative study evaluated a dissolving microneedle patch containing acetyl octapeptide-3 plus several other active materials against a hyaluronic-acid placebo patch. Another 12-week study evaluated a microneedle product containing acetyl octapeptide-3 and multiple bioactives.
- Important limit
- Those studies evaluate complete multi-component patches, not acetyl octapeptide-3 alone or the catalog's 200 mg raw material. They cannot establish ingredient-specific effects or verify the catalog lot.
FACTUAL FAQ
SNAP-8 catalog questions
What formats are currently listed?
200 mg. Current price and stock state appear above.
What did researchers study?
A 24-person comparative study evaluated a dissolving microneedle patch containing acetyl octapeptide-3 plus several other active materials against a hyaluronic-acid placebo patch. Another 12-week study evaluated a microneedle product containing acetyl octapeptide-3 and multiple bioactives.
What is the most important evidence limit?
Those studies evaluate complete multi-component patches, not acetyl octapeptide-3 alone or the catalog's 200 mg raw material. They cannot establish ingredient-specific effects or verify the catalog lot.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →
